UiPath officer amends insider sale and updates share holdings
UiPath, Inc. reported an amended insider transaction for its Chief Accounting Officer.
Rhea-AI Filing Summary
UiPath, Inc. reported an amended insider transaction for its Chief Accounting Officer. The officer sold 5,000 shares of Class A common stock on 10/22/2025 at an average price of $15.4673, under a qualified selling plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934.
The filing clarifies that the price range for the trades was from $15.3200 to $15.8000. It also corrects a clerical error in previously reported holdings: the officer’s beneficial ownership after the transaction is now stated as 187,776 shares, instead of the earlier reported 182,776 shares. No other changes were made.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Class A Common Stock | 5,000 | $15.4673 | $77K |
Footnotes (3)
- F1. These shares were sold in compliance with a qualified selling plan adopted by the Reporting Person pursuant to Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.
- F2. The range of prices for the transactions reported was from $15.3200 to $15.8000. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.
- F3. This Form 4/A is being filed to correct a clerical error in the total number of securities beneficially owned reported on the Form 4 filed on October 22, 2025. The total number of securities beneficially owned by the reporting person was inadvertently reported as 182,776 shares and should have been reported as 187,776 shares. No other changes have been made.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did UiPath (PATH) report in this Form 4/A?
Why was this UiPath (PATH) Form 4/A filed as an amendment?
Was the UiPath (PATH) insider sale made under a Rule 10b5-1 trading plan?
Does this UiPath (PATH) Form 4/A involve any derivative securities?
AI-generated analysis. How Rhea-AI works. Not financial advice.